The nitric oxide synthase (NOS) inhibitors, ni tro-L-arginine, its methyl ester, and N-monomethyl-L arginine, have been shown to attenuate resting CBP and hypercapnia-induced cerebrovasodilation. Those agents nonspecific ally inhibit the endothelial and neuronal NOS (eNOS and nNOS). In the present study, we used a novel nNOS inhibitor, 7-nitroindazole (7-NI) to examine the role of nNOS in CBP during normocapnia and hypercap nia in fentanyUN20-anesthetized rats. CBP was moni tored using laser-Doppler flowmetry. Administration of 7-NI (80 mg kg-I i.p.) reduced cortical brain NOS activ ity by 57%, the resting CBP by 19-27%, and the CBP response to hypercapnia by 60%. The 60% reduction was similar in magnitude to the CBP reductions observed in previous studies in which nonspecific NOS inhibitors
Nitric oxide (NO) has emerged as an important endogenous modulator of brain function, and has been shown to play a role in the cerebral vasodila tory responses (CVDRs) to a wide variety of stim uli, including, muscarinic agonists, neuronal activa tion, volatile anesthetics, hypoxia, and hypercapnia (Iadecola et aI., 1994) . NO is produced by the action of NO synthase (NOS) (Luscher and Vanhoutte, 1990) . In the brain, NOS is not only located in the were used. In the pre�ent study, 7-NI did not increase the MABP. ,Furthermore, the CBP response to oxotremo rine, a blood-brain barrier permeant muscarinic agonist that induces cerebrovasodilation via endothelium-derived NO, was unaffected by 7-NI. These results confirmed that 7-NI does not influence eNOS; they also indicated that the effects of 7-NI on the resting CBP and on the CBP response to hypercapnia in this study were solely related to its inhibitory action on nNOS. The results fur ther suggest that the NO synthesized by the action of nNOS participates in regulation of basal CBP and is the major, if not the only, category of NO contributing to the hypercapnic CBP response. Key Words: Hypercapnia-7 -NI-N itric oxide-eN OS-nN OS-Oxotremorine. endothelium, but also in neurons, perivascular nerves, and astrocytes (Bredt et aI., 1990; Murphy et aI., 1993) . There are at least two constitutive NOS (cNOS) isoforms in the brain (i.e., the endo thelial [eNOS] and neuronal [nNOS] forms) that generate NO phasically (Moncada et aI., 1991) . Ow ing to the rapidity of the CVDRs to the above stim uli, it is clear that a cNOS is involved. Previous studies of NO influences in the rat have used non specific NOS inhibitors (e.g., nitro-L-arginine) and found that such agents significantly attenuated the resting CBF and the CBF response to hypercapnia (PaC02 = 60-80 mm Hg) (Iadecola et aI., 1994) . However, the mechanism by which hypercapnia elicits NO release and the cellular source of that NO are not known. Recently, a selective inhibitor of the nNOS, 7-nitroindazole (7-NI) was identified (Moore et aI., 1993) . In the present study, we monitored cortical CBF in rats in the presence of 7-NI and examined the role of nNOS in regulation of CBF during normo-and hypercapnic conditions. To con-firm that eNOS was unaffected by 7-NI, we exam ined the CBF responses to the muscarinic agonist, oxotremorine (OXO), which, like acetylcholine, ac tivates eNOS exclusively (Pelligrino et aI. , 1992) .
MATERIALS AND METHODS
The study protocol received Institutional Animal Care and Utilization Committee approval. Experiments were performed on male Sprague-Dawley rats (350-450 g). The laser-Doppler probe holders were placed 1-2 days prior to experimentation, with the animals anesthetized with 1 % halothane in 70% N20:30% O2, intubated, and mechani cally ventilated. The skull over the right parietal cortical area was thinned to translucency, but the dura was not exposed. The potential for local tissue and vascular injury was therefore minimized. During the thinning, the bone was continuously cooled with a jet of air to avoid over heating of the area. Then, an inverted 20 g needle adaptor was glued over the thinned bone "window" for holding the laser-Doppler probe. On the day of the experiment, anesthesia was induced with halothane and the rat was paralyzed (curare), tracheotomized, and mechanically ventilated. Surgical anesthesia for insertion of bilateral femoral arterial and venous catheters consisted of 1 % halothane in 70% N20:30% O2, Following catheteriza tion, the halothane was discontinued and a loading dose of fentanyl (10 J.Lg kg-I i.v.) was given. Anesthesia during the study was fentanyl (25 J.Lg kg -I h -I i. v.) plus venti lation with 70% N20:30% O2,
In all experiments, initial CBF baseline measurements were made at ;3 1 hour post halothane by laser-Doppler (Periflux PF3, Perimed, Stockholm, Sweden). This is suf ficient time for the cerebral circulatory and metabolic ef fects of halothane to have returned to normal (Berntman et aI., 1976) . The first CBF response to 5 min hypercapnia was measured prior to 7-NI or vehicle injection. Then 7-NI (80 mg kg-I in 3 ml corn oil) or vehicle (3 ml corn oil) was injected i.p. (n = 7 and n = 6, respectively). CBF responses to 5 min hypercapnia were measured at 30 and 60 min postinjection. After an additional 15-20 min, the CBF response to a 7 min i. v. infusion of OXO (1 fl.g kg -I min -I), a blood-brain barrier permeant muscarinic agonist, was measured. To minimize systemic cardiovas cular influences of muscarinic receptor activation, the blood-brain barrier impermeant muscarinic antagonist, atropine methyl bromide (AMB), was injected (0.5 mg kg-I i.p.) 10-15 min before OXO infusions in both vehi cle and 7-NI groups. With AMB, the blood pressure was maintained at -140 mm Hg in both groups. At the end of the study, the heart was stopped by a bolus injection of 1 ml 95% alcohol i. v., and the zero level for CBF was re corded.
Brain NOS activity assay
Immediately after the experiment, the rat brain was removed and cortical tissue (-100 mg) was rapidly ex cised and frozen. The tissue was then stored in a -80°C freezer until the NOS assay was performed on the follow ing day. The assay is based on the in vitro conversion of [14C]arginine to [14C]citrulline in homogenates (Bredt and Snyder, 1989; Irikura et aI., 1994) . After being weighed, the samples were homogenized for 30 sec in 500 fl.l of 50 mM N-2-hydroxyethylpiperazine-N' -2-ethanesulfonic acid (HEPES, pH 7.4) and 1 mM ethylenediamine tetraacetic acid (EDTA, pH 7.4). Homogenate was then centrifuged at 2,000-3,000 RPM for 5 min at 4°C. Twenty five microliters of supernatant was combined with 25 fl.l of diluted 14C radioactive tracer (1 mCi/ml, NENlDupont, Boston, MA, U.S.A.) and 100 fl.l reaction buffer (HEPES 50 mM, EDTA 1 mM, I3-NADPH 1 mM, and Ca 2 + 1 mM, pH 7.4). The mixture was reacted at room temperature for 10 min and stopped with stop solution (HEPES 20 mM and EDTA 2 mM, pH 5.5). 
RESULTS
As illustrated in Fig. 1, 7 -NI significantly reduced the basal CBF. When compared to mean values for vehicle-treated animals, the mean reductions were 19, 21, and 27% at 30, 60, and 80 min, respectively, after 7-NI injection (p < 0. 05). No changes in MABP, Pacoz, or arterial pH were noted during the experiments, in either control or 7-NI-treated rats (Table 1) .
During hypercapnia, P aco2 was increased to 70-80 mm Hg, with no significant differences observed when comparing hypercapnic episodes (Table 2) . MABP remained constant throughout the studies (at 120-140 mm Hg) and was unaffected by 7-NI treatment ( Table 2 ). In vehicle-treated animals, the CBF responses to hypercapnia prior to and 30 and 60 min after vehicle treatment were nearly identical. In the 7-NI-treated group, the CBF responses to hypercapnia were significantly reduced at 30 and 60 min after 7-NI treatment, in comparison with both the 7-NI group pretreatment value and the control group 30 and 60 min values (Fig. 2) . Although there were some differences in P aco2 levels between ve hicle-and 7-NI-treated animals (-80 vs. -70 mm Hg), this can be corrected by expressing the CBF response to hypercapnia as CO2 reactivity (% CBF change/mm Hg Paco2 increase). According to these calculations, 7-NI attenuated CO2 reactivity by 60% (Table 2) . Treatment with 7-NI also inhibited brain NOS activity, by 57 ± 15%. However, the CBF response to OXO was not affected by 7-NI ( Fig. 3) .
DISCUSSION
Previous studies have shown that NO is partly responsible for the cerebral hyperemia associated with hypercapnia (see Iadecola et aI., 1994) . Those studies used the NOS inhibitors, nitro-L-arginine (L-NA), its methyl ester (L-NAME), and N-mono methyl-L-arginine (L-NMMA); the inhibitors caused a marked reduction of CBF response to hy percapnia in rat, cat, dog, and rabbit. The reduced CO2 reactivity was not due to its pressor effect (Wang et aI., 1992) and could be prevented by large doses of L-arginine (Wang et aI., 1992; Iadecola, 1992) . The magnitude of the reduction depended on the dose and route of administration of the inhibi tor. With systemic administration (intravenous, in tracarotid), the reduction was about 42-75% (lade cola et aI. , 1994) .
It is generally accepted that L-NA, L-NAME, and L-NMMA are nonspecific inhibitors, acting on both eNOS and nNOS (Lambert et aI., 199 1) . Thus, it is not possible to establish from earlier studies employing these inhibitors which cNOS isoform is involved in the CBF response to hypercapnia. Re cent evidence from our group demonstrated that the CO2-induced vasodilation in pial arterioles was nor mal after endothelial injury (Wang et aI., 1994b) . This suggests an exclusive role for nNOS in the NO-dependent portion of the hypercapnic re sponse. Nevertheless, these results do not exclude the possibility that endothelium in large arteries may play a role in hypercapnic cerebral vasodila tion. Using 7-NI in the present study, we were able to address this issue. We found that 7-NI, a nNOS inhibitor, significantly attenuated the CBF response to hypercapnia. The 60% reduction in that response was of a similar magnitude to that observed in ear lier studies using nonspecific NOS inhibitors (lade cola et aI. , 1994) . This implies that most and per haps all of the NO released during hypercapnia de rives from nNOS. At this stage, we cannot conclude that perivascular neurons are the exclusive source of the NO released in response to hypercapnia. An astroglial cNOS has been identified (Murphy et aI. , 1993) , but it is not known whether it is identical to nNOS and inhibitable by 7-NI.
Consistent with the findings of Moore et al. (1993) , we did not observe any increase in MABP following 7-NI. Moreover, 7-NI did not affect the CBF response to OXO, a muscarinic agonist that, like acetylcholine, dilates cerebral vessels through eNOS (Pelligrino et aI., 1992) . We previously re ported that intravenous L-NAME in rats com pletely blocked the CBF increase to OXO (Pelli -TABLE 1 . Arterial blood variables under normocapnic condition in vehicle control and 7-NI-treated rats Vehicle (n = 6) 7-NI (n = 7) grino et aI., 1992) and, as reported by many others, increased MABP (for review, see Iadecola et aI., 1994) . The absence of any influence of 7-NI on blood pressure and on the CBF response to OXO confirmed that, unlike L-NAME or other nonspe cific NOS inhibitors, 7-NI does not have an effect on eNOS.
There is evidence in support of a basal NO re lease in cerebrovascular endothelium. NOS inhibi tors reduce the vascular diameter in isolated large cerebral arteries and decrease their cyclic GMP content (Alafaci et aI., 1993; Cosentino et ai, 1993; Wang et aI., 1993) . In the present study, 7-NI sig nificantly reduced basal CBF by 19-27%. That fall in CBF is somewhat smaller in magnitude than the 30-50% reduction in CBF we previously observed in rats following L-NAME or L-NA administration (Wang et aI., 1992; Wang et aI., 1994a; Pelligrino et aI., 1993) . Taken together, these results suggest that both nNOS-and eNOS-derived NO are responsible for the basal NQ "tone."
The possibility that 7-NI can directly dilate cere bral vessels (Medhurst et aI., 1994) or inhibit the inducible NOS (Wolff and Gribin, 1994) merits some consideration. Such effects of 7-NI might have influenced the findings of the present study. Indeed, if NOS-independent relaxation by 7-NI can also be elicited in rat cerebral arteries in vivo (the Medhurst et al. studies were conducted using iso lated dog arteries), the constrictive action of 7-NI we observed under basal and hypercapnic condi tions would represent an underestimation of the ef fects of nNOS inhibition. The possible effects of 7-NI on inducible NOS (iNOS) activity should be of little or no concern in the present study for a num- ber of reasons. First, 7-NI was shown to be 30-40 times more potent in inhibiting cNOS than in inhib iting iN OS (Wolff and Gribin, 1994) . Second, iN OS activity in the normal rat brain is virtually undetect able (ladecola et aI., 1995a,b) . Third, as discussed in our previous study (Wang et aI., 1994b) , the fast vasodilatory response to CO2 rules out the possible involvement of iNOS because the process of induc tion requires many hours (Moncada et aI., 1991) . Furthermore, once activated, iNOS produces NO continuously. The fact that the vascular response to hypercapnia was rapidly reversed following resto ration of normocapnia also speaks against any role of iNOS in hypercapnia-induced cerebrovasodila tion. Thus, we are confident that the NOS inhibiting action of 7-NI relates specifically to the constitutive nNOS isoform.
In conclusion, 7-NI did not affect endothelium dependent cerebrovasodilation or MABP, but sig nificantly reduced resting CBF and the CBF re sponse to hypercapnia. The first two findings sug gest that the effects of 7-NI in the present study are substantially due to its inhibitory action on nNOS. The results also indicate that NO released by the action of nNOS participates in the regulation of basal CBF and the hypercapnic CBF response. Fur thermore, the NO source during hypercapnia is nonendothelial.
